G

ood morning, everyone, and how are you today? We are doing just fine, thank you, especially now that we have downed yet another cup of stimulation. For those who care, our flavor today has traces of Tennessee whiskey, and it already comes this way, believe it or not. In any event, feel free to join us or grab a bottle of whiskey-free water, if you prefer. Meanwhile, here are some items of interest. Have a lovely day and do keep in touch …

India’s health ministry recommended waiving clinical trials for critical drugs to treat such diseases as HIV, hepatitis, and tuberculosis if the medicines have already been approved in markets such as the U.S., Japan, the European Union, Canada, and Australia at least two years ago, the Economic Times informs us. However, some doctors tell PharmaBiz they have concerns about this policy.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.